Cargando…
Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles
Multiple myeloma (MM) is a cancer of differentiated plasma cells that occurs in the bone marrow (BM). Despite the recent advancements in drug development, most patients with MM eventually relapse and the disease remains incurable. RNA therapy delivered via lipid nanoparticles (LNPs) has the potentia...
Autores principales: | Tarab‐Ravski, Dana, Hazan‐Halevy, Inbal, Goldsmith, Meir, Stotsky‐Oterin, Lior, Breier, Dor, Naidu, Gonna Somu, Aitha, Anjaiah, Diesendruck, Yael, Ng, Brandon D., Barsheshet, Hagit, Berger, Tamar, Vaxman, Iuliana, Raanani, Pia, Peer, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375190/ https://www.ncbi.nlm.nih.gov/pubmed/37171801 http://dx.doi.org/10.1002/advs.202301377 |
Ejemplares similares
-
Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles (Adv. Sci. 21/2023)
por: Tarab‐Ravski, Dana, et al.
Publicado: (2023) -
P1355: DELIVERY OF THERAPEUTIC RNA TO THE BONE MARROW IN MULTIPLE MYELOMA USING CD38-TARGETED LIPID NANOPARTICLES
por: Tarab-Ravski, Dana, et al.
Publicado: (2023) -
A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery
por: Naidu, Gonna Somu, et al.
Publicado: (2023) -
A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery (Adv. Sci. 19/2023)
por: Naidu, Gonna Somu, et al.
Publicado: (2023) -
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium
por: Kon, Edo, et al.
Publicado: (2023)